First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle

BERLIN, Oct. 28, 2026 /PRNewswire/ — Appian (Nasdaq: APPN) and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new offering automates clinical trial site identification and selection across therapeutic areas, indications, and geographies.

The live solution is the first step in a shared vision by PSI and Appian to build a scalable platform that connects automation, AI-powered capabilities, and process orchestration across the full clinical trial lifecycle. Together, the companies are creating a foundation designed to improve efficiency, transparency, and speed across complex clinical trial processes.

AI and process orchestration for complex site selection
Clinical trial site selection is a highly coordinated process involving multiple stakeholders, large volumes of documentation, and parallel activities across countries and regions. The new solution brings previously manual, decentralised steps into a single digital process, from project initiation through the subsequent stages of site selection.

Recognised by Gartner as a Leader in the 2026 Gartner® Magic Quadrant™ for Business Orchestration and Automation Technologies (BOAT), we believe the Appian Platform provides the foundation for this solution. It identifies and selects the most suitable study sites for sponsors, providing greater end-to-end visibility and enabling faster execution across the site selection process.

The solution goes beyond task automation to orchestrate the end-to-end process, connecting people, data, systems, and AI in a single workflow. It coordinates activities across teams and geographies and automates information and document processing. It also manages routing and exceptions, providing real-time insight into process performance.

The solution integrates with PSI’s core systems and data warehouse, as well as Appian’s AI and process intelligence capabilities. The integrated solution creates a scalable foundation for faster decisions, greater consistency, and continuous improvement.

Starting point for a long-term platform strategy
The site selection solution puts PSI’s platform vision into practice. It combines PSI’s focus on predictable clinical trial delivery with Appian’s process automation and AI capabilities.

“The AI-powered clinical trial site selection solution is an important step in how we are rethinking and connecting our operational processes,” says Kirill Soldatov, Head of Process Improvement at PSI. “PSI is known for our ability to deliver complex clinical trials on time. Building a more connected operational model through automation, AI-powered capabilities, and process orchestration within our existing workflows creates a scalable foundation for more predictable, accurate, and timely site selection worldwide, with the goal to further reduce or eliminate non-enrolling sites and patient enrollment delays.”

“This initial project demonstrates the value AI can create when it is embedded in business processes. The solution helps PSI process information faster with automation and manage processes with greater transparency with orchestration. Through our strategic partnership with PSI, we aim to create a flexible, long-term foundation for further automation and innovation,” adds Alexander Motie, Regional Vice President DACH & Eastern Europe at Appian.

With the first solution now live, PSI and Appian will build on this foundation by evaluating further use cases to extend AI-powered process orchestration across the clinical trial lifecycle. The goal is to shorten clinical studies and increase predictability, thus introducing new products to market and driving down costs for consumers.

Find out how life sciences companies can use AI automation for faster speed to market here.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding future product capabilities, strategic plans, and industry growth, are forward-looking. These statements are subject to risks and uncertainties that could cause actual results to differ materially. Appian undertakes no obligation to update forward-looking statements.

About PSI CRO
PSI is a global full-service contract research organisation (CRO), committed to being the best CRO in the world as measured by its customers, investigators, and vendors, and employees. PSI’s key operational differentiator is on-time delivery of clinical trials. This metric is still above 90% in 2026.

The company specialises in pivotal clinical trials in oncology, gastroenterology, hematology, immunology, infectious diseases, neurology, among other indications. PSI provides expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.

In 2025, PSI celebrated its 30th year of business as the only fully independent and privately owned mid-sized CRO. PSI employs over 3,500 people across 58 countries as of September, 2026.

Global headquarters are in Switzerland at 113a Baarerstrasse, Zug 6300.
For more information, visit www.psi-cro.com.

About Appian
Appian provides AI automation for the most important business processes at the world’s largest organisations.

On the Appian Platform, customers build AI-powered processes that accelerate work, reduce cost, and manage risk. Our platform is known for its unique power, reliability, and scale. We’ve been automating processes for more than 25 years and have proven expertise in enterprise operations. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian DACH: LinkedIn, Youtube, Instagram, Facebook, and X.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/appian-and-psi-cro-form-strategic-partnership-to-advance-ai-driven-clinical-trial-operations-302921701.html

For the 2026 Technology Fast 50 award category, Finni Health takes first place this year, achieving more than 46,000% revenue growth over four years. Across all 2026 winners, average revenue growth exceeded 3,000%. For the first time in the program’s history, half of the companies in the top 10 Technology Fast 50 winners are led by women CEOs.

TORONTO, Oct. 28, 2026 /CNW/ — Deloitte Canada is proud to announce the winners of its 2026 Technology Fast 50™ program. Now in its 29th year, the program recognizes the world-class achievements of Canada’s fastest-growing technology companies and celebrates their confidence, resilience, entrepreneurial spirit and commitment to innovation.

 This year’s Technology Fast 50 cohort achieved an average growth rate of 3,079%, surpassing the 3,000% mark for the first time in recent years. Despite tighter capital markets, economic uncertainty, and competitive pressure, the winners continue to invest, hire, innovate, and scale.  Their achievements underscore the strength of Canada’s technology sector and dispel any notion that tech firms struggle to achieve high growth while headquartered in Canada.

“The strongest signal from the 2026 Technology Fast 50 class is confidence,” says Brendan Cooper, Partner and National co-leader for the Technology Fast 50 program at Deloitte Canada. “These Canadian companies have been shaped by disruption and proven through crunch periods. That resilience is showing in how they lead today. They are investing, hiring, and innovating through uncertainty with confidence.”

Many of this year’s fastest-growing companies were founded or began scaling around the pandemic, meaning their leaders have navigated disruption from the outset. That resilience is increasingly translating into bolder execution. In 2026, roughly 70% of applicants identified marketing and customer acquisition as a priority; more than 55% selected capital raising; and more than 50% identified strategic mergers and acquisitions as a priority.

“This year’s winners are moving from cautious ambition to bold execution,” says Amanda Perran, Partner and National co-leader for the Technology Fast 50 program at Deloitte Canada. “These companies have excelled through their relentless focus on the fundamentals of growth: winning customers, attracting investment, building strong teams, and pursuing new opportunities. The next stage of their journey will be defined by how effectively they combine that ambition with the capital, talent, and AI-enabled capabilities needed to create sustainable, long-term value.”

Talent and innovation remain central to the growth agenda. Applicants identified workforce planning as their most pressing anticipated challenge, while technical upskilling and acquiring specialized skills emerged as leading talent priorities. At the same time, according to a new Deloitte report, close to 70% of qualifying companies devote a significant portion of revenue to research and development, and more than 85% expect AI to deliver productivity gains.

2026 winners: a new generation of Canadian technology leaders

Finni Health tops this year’s Technology Fast 50 category, posting four-year revenue growth of 46,574%. Headquartered in Toronto, Ontario, the company provides a platform that enables autism care providers (BCBAs) to launch, run, and scale their own private Applied Behavior Analysis (ABA) practices.

In the Enterprise–Industry Leaders category, UniUni secured first place with four-year revenue growth of 2,143%. Headquartered in Vancouver, British Columbia, the company is a logistics company that provides delivery services to leading ecommerce and retail brands.

Meanwhile, Turbopuffer was recognized as the number one winner in the Companies-to-Watch category, achieving three-year revenue growth of 65,443%, highest per cent growth in the National Capital Region in the past 5 years. Headquartered in Ottawa, Ontario, the company is a vector and full text search database purpose-built on object storage.

These standout companies are not only advancing their respective industries but also reinforcing Canada’s reputation as a source of globally competitive technology and innovation.

Winner selection is based solely on revenue growth requirements. Each participating company must submit audited or reviewed financial statements to qualify for the program.

Technology Fast 500™ ranking

The Technology Fast 50 awards program runs alongside the broader North American Technology Fast 500™. This year, over 80 Canadian companies made the list. The complete list of Technology Fast 500 winners will be released on November 18.  

For more information on the Technology Fast 50, Enterprise–Industry Leaders, and Companies-to-Watch categories, please visit www.fast50.ca.

About the Deloitte Technology Fast 50 program

The Deloitte Technology Fast 50 program is Canada’s pre-eminent technology awards program. It recognizes business growth, innovation and entrepreneurship in three distinct categories: Technology Fast 50, Enterprise–Industry Leaders and Companies-to-Watch. The program also celebrates thriving technology companies in partnership with the North American Technology Fast 500™ program. Program sponsors for 2026 include RBCx, Norton Rose Fulbright, Export Development Canada, TMX, the Council of Canadian Innovators. For more information, visit www.fast50.ca.

About Deloitte Canada

At Deloitte, our Purpose is to make an impact that matters. We exist to inspire and help our people, organizations, communities, and countries to thrive. Our work underpins a prosperous society where people can find meaning and opportunity. It builds consumer and business confidence, empowers organizations to find imaginative ways of deploying capital, enables fair, trusted, and functioning social and economic institutions, and allows our friends, families, and communities to enjoy the quality of life that comes with a sustainable future. And as the largest Canadian-owned and operated professional services firm in our country, we are proud to work alongside our clients to make a positive impact for all Canadians.

Deloitte provides industry-leading consulting, audit and assurance, tax, advisory and managed services to nearly 90% of the Fortune Global 500® and thousands of private companies. We bring together world-class capabilities, insights, and services to address clients’ most complex business challenges.

Deloitte LLP, an Ontario limited liability partnership, is the Canadian member firm of Deloitte Touche Tohmatsu Limited. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

To learn more about Deloitte Canada, please connect with us on LinkedIn, X, Instagram, or Facebook.

© 2026 Deloitte LLP and affiliated entities.

SOURCE Deloitte Canada

Streamline your Q3 tax deadline on Monday, November 2, 2026, while managing invoices, purchase orders, and payroll inside the secure, offline ezAccounting platform.

REDMOND, Wash., Oct. 28, 2026 /PRNewswire/ — Halfpricesoft.com has released critical feature enhancements to its comprehensive ezAccounting software, giving small business owners and accountants an immediate, reliable path to meet the upcoming third-quarter IRS Form 941 electronic filing deadline on Monday, November 2, 2026. By removing the friction of paper-based mailing, ezAccounting allows organizations to process and transmit their quarterly tax documentation straight to federal servers from their desktop while seamlessly tying those records to daily operations like client invoicing and vendor orders.

Download and test ezAccounting today to experience automated, paperless 941 electronic filing before the November 2nd deadline.

“Small businesses need robust, self-contained financial tools that handle daily cash flow and seasonal tax deadlines simultaneously,” said Dr. Ge, Founder of Halfpricesoft.com. “ezAccounting delivers full-scale operations—from tracking customer invoices to direct tax filing—in an intuitive interface backed by responsive customer support.”

The 2026-2027 ezAccounting suite is currently available at a promotional bundle price 2026 + 2027 Bundle for $319 (regularly $418.00)

Evaluating the software now with our 30-day free trial allows teams to verify compatibility, begin secure data input, and establish a clean financial foundation well ahead of year-end reporting. Start today!

Get the details of the streamlined e941 add-on feature available with ezAccounting purchase.

All-in-One Local Financial Management

While ezAccounting streamlines your quarterly e-filing obligations, the platform is engineered to serve as a complete, independent business accounting ecosystem. It manages day-to-day business accounting without monthly subscription fees through several built-in modules:

Custom Invoicing & AR: Generate, print, or email professional customer invoices, track accounts receivable, and process incoming customer payments to maintain an accurate cash flow ledger.Purchase Orders & AP: Streamline vendor management by creating official purchase orders, tracking inventory arrivals, and managing accounts payable to ensure bills are paid on time.Offline Data Privacy: Unlike cloud-based SaaS accounting software, ezAccounting installs locally on your computer. Your financial data, profit margins, and employee information remain completely offline and protected.Built-in Check Printing & Payroll: Design and print custom checks on blank check stock for both vendor payments and employee payroll, completely eliminating the ongoing expense of pre-printed checks.Comprehensive Tax Compliance: Automatically updates to match shifting federal and state tax codes, ensuring error-free generation of Forms W-2, W-3, 940, 943, and 941.

Eliminate the risk of late filing fines this quarter. Download the 30-day free trial of ezAccounting today with no credit card required, or lock in the 2026-2027 ezAccounting Bundle for just $319 (discounted from $418).

About Halfpricesoft

Halfpricesoft is a premier developer of straightforward, high-efficiency business software solutions, specializing in payroll systems, check printing utilities, and tax compliance automation. Serving over 20,000 small businesses and accounting practices nationwide since 2003, the company focuses on delivering robust, localized software architectures that eliminate high recurring enterprise costs.

View original content to download multimedia:https://www.prnewswire.com/news-releases/meet-the-nov-2-deadline-risk-free-ezaccounting-software-automates-q3-irs-form-941-e-filing-and-core-business-operations-302914003.html

SOURCE Halfpricesoft.com